Cipla gains on settling trademark suit with Bayer Healthcare

08 Dec 2011 Evaluate

Cipla is currently trading at Rs. 325.70, up by 0.90 points or 0.28% from its previous closing of Rs. 324.85 on the BSE.

The scrip opened at Rs. 324.85 and has touched a high and low of Rs. 329.00 and Rs. 321.35 respectively. So far 69628 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 380.80 on 04-Jan-2011 and a 52 week low of Rs. 273.60 on 06-Sep-2011.

Last one week high and low of the scrip stood at Rs. 332.50 and Rs. 321.35 respectively. The current market cap of the company is Rs. 26082.90 crore.

The promoters holding in the company stood at 36.80% while Institutions and Non-Institutions held 33.43% and 29.62% respectively.

Cipla has settled a trademark infringement case with German drug major Bayer Healthcare after it found Cipla's veterinary products were entering into the United States market, through Web site channels.

As per the settlement, Cipla will give up all profits it made from the sale of its DA Double Advantage, amounting in excess of $100,000, and discontinue all use of the trademark. It will also stop use of the trademark 'Advance' for a companion animal product and not make any product with the same formula as Bayer's Advantix, another patented flea preventative, during the remaining term of those patents.

Website operator Archipelago agreed to a consent decree, under which it is prohibited from selling DA Double Advantage and Advantix in the United States.

Cipla Share Price

1465.65 -5.70 (-0.39%)
21-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.65
Dr. Reddys Lab 1194.55
Cipla 1465.65
Lupin 2043.30
Zydus Lifesciences 944.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.